Oniot, Mary Joy .

HRN: 21-41-27  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/30/2022
05/31/2022
IV
500mg
Q8 X 4 Doses
Post Op Prophylaxis
Waiting Final Action 
05/30/2022
CEFUROXIME 1.5GM (VIAL)
05/30/2022
05/30/2022
IV
1.5g
Q8 X 3 Doses
Post Op Prophylaxis
Waiting Final Action 
05/30/2022
CEFUROXIME 500MG (TAB)
05/30/2022
06/05/2022
ORAL
500mg
BID
S/P LTCS MSAF
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: